The Potential of Silver Nanoparticles in Anti-cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 191
Special Issue Editors
Interests: biochemistry; genetics and epigenetics; molecular biology; extracellular vesicles; nanomedicine; biological sciences
Special Issues, Collections and Topics in MDPI journals
Interests: biology; genetics and epigenetics; molecular biology; extracellular vesicles and biological sciences; health; nanomedicine; oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, extensive research has been initiated on the potential of nanomedicine in future anti-cancer therapies. Among different nanomedicines are the silver nanoparticles (AgNPs), which, due to their physical–chemical properties and the ability to functionalize their surface chemistry, have consistently shown antitumor properties in different tumor models. AgNPs are small, organized structures ranging from 1 to 100 nm in size with 20 to 15000 atoms. Their easy and inexpensive synthesis makes them an attractive approach in the design of anti-cancer therapies, and some studies have shown their potential alone or in combination in several tumor models, including the ones resistant to current therapies.
Therefore, this Special Issue aims to highlight the possibility of AgNP usage in new therapies in the cancer context, covering their physical and chemical characterization, functionalization possibilities, antitumor potential, and biocompatibility, both in vitro and in vivo in the different oncological sets, including the therapy-resistant ones.
Dr. Mariana Morais
Dr. Ana Luísa Teixeira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- silver nanoparticles
- nanomedicine
- cancer
- oncology
- therapy resistance
- nanotechnology
- nanoparticle functionalization
- nanotoxicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
